NO996438L - Ny kombinasjon av antiastmamedikamenter - Google Patents

Ny kombinasjon av antiastmamedikamenter

Info

Publication number
NO996438L
NO996438L NO996438A NO996438A NO996438L NO 996438 L NO996438 L NO 996438L NO 996438 A NO996438 A NO 996438A NO 996438 A NO996438 A NO 996438A NO 996438 L NO996438 L NO 996438L
Authority
NO
Norway
Prior art keywords
new combination
asthma drugs
kit
active ingredient
asthma
Prior art date
Application number
NO996438A
Other languages
English (en)
Norwegian (no)
Other versions
NO996438D0 (no
Inventor
Bengt Axelsson
Leif Kollstroem
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996438D0 publication Critical patent/NO996438D0/no
Publication of NO996438L publication Critical patent/NO996438L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO996438A 1997-06-27 1999-12-23 Ny kombinasjon av antiastmamedikamenter NO996438L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88382397A 1997-06-27 1997-06-27
PCT/SE1998/001089 WO1999000134A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments

Publications (2)

Publication Number Publication Date
NO996438D0 NO996438D0 (no) 1999-12-23
NO996438L true NO996438L (no) 2000-02-28

Family

ID=25383399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996438A NO996438L (no) 1997-06-27 1999-12-23 Ny kombinasjon av antiastmamedikamenter

Country Status (16)

Country Link
EP (1) EP1009408A1 (pt)
JP (1) JP2002510310A (pt)
KR (1) KR20010014162A (pt)
AU (1) AU8135098A (pt)
BR (1) BR9810452A (pt)
CA (1) CA2295076A1 (pt)
EE (1) EE9900594A (pt)
HU (1) HUP0002533A3 (pt)
ID (1) ID24063A (pt)
IL (1) IL133597A0 (pt)
IS (1) IS5303A (pt)
NO (1) NO996438L (pt)
PL (1) PL337722A1 (pt)
SK (1) SK184799A3 (pt)
TR (1) TR199903272T2 (pt)
WO (1) WO1999000134A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0009617D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AU2003263717A1 (en) * 2002-09-25 2004-04-19 Astrazeneca Ab A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
DK0613371T3 (da) * 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
JP2002510310A (ja) 2002-04-02
ID24063A (id) 2000-07-06
EE9900594A (et) 2000-08-15
SK184799A3 (en) 2000-06-12
HUP0002533A3 (en) 2001-03-28
AU8135098A (en) 1999-01-19
PL337722A1 (en) 2000-08-28
IL133597A0 (en) 2001-04-30
NO996438D0 (no) 1999-12-23
IS5303A (is) 1999-12-15
HUP0002533A2 (hu) 2000-12-28
WO1999000134A1 (en) 1999-01-07
EP1009408A1 (en) 2000-06-21
BR9810452A (pt) 2000-09-05
TR199903272T2 (xx) 2000-08-21
CA2295076A1 (en) 1999-01-07
KR20010014162A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
NO950774L (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
NO982414L (no) Ny kombinasjon
NO20005431L (no) Gelerbare farmasoytiske preparater
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
ES2185307T3 (es) Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion.
BRPI0009956A (pt) composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
NO20076019L (no) Utvortes preparat for hud
BRPI0408990A (pt) derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase
BR9611802A (pt) Composições farmacêuticas
CA2213989A1 (en) External preparation for topical administration
BR0211673A (pt) Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
HUP0004396A2 (hu) A lipoprotein-oxidáció gátlására szolgáló, hatóanyagként hidroxilezett koleszterincsökkentő szert tartalmazó gyógyszerkészítmények
PT99597B (pt) Processo para a preparacao de derivados do acido hidroxamico que inibem a lipoxigenase
EP0727217A3 (en) Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient
NO996438L (no) Ny kombinasjon av antiastmamedikamenter
PA8559401A1 (es) Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
BR0317567A (pt) Composição farmacêutica de liberação controlada de tamsulosina e processo para sua preparação
DE59608698D1 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application